Survival benefit of primary prevention implantable cardioverter- defibrillator therapy after myocardial infarction: Does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials

Heart Rhythm

Volumn 10, Issue 6, 2013, Pages 828-835

  Hess, Paul L ^a   Laird, Amy ^b   Edwards, Rex ^a   Bardy, Gust H ^b   Bigger, J Thomas ^c   Buxton, Alfred E ^d   Moss, Arthur J ^e   Lee, Kerry L ^a   Hall, W J ^e   Steinman, Richard ^c   Dorian, Paul ^f   Hallstrom, Al ^b   Cappato, Riccardo ^g   Kadish, Alan H ^h   Kudenchuk, Peter J ^b   Mark, Daniel B ^a   Al Khatib, Sana M ^a   Piccini, Jonathan P ^a   Inoue, Lurdes Y T ^b   Sanders, Gillian D ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Columbia University ^*  (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g IRCCS POLICLINICO SAN DONATO   (Italy)

^h NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Heart failure; Implantable cardioverter defibrillator; Myocardial infarction; Sudden cardiac death

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HOSPITAL READMISSION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; SURVIVAL; THERAPY EFFECT;

AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS;

EID: 84883253090     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2013.02.011     Document Type: Article

References (34)

1. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345: 1473-1482.
2. Moss AJ, Hall WJ, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defib-rillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335: 1933-1940.
3. Moss AJ, Zareba W, Hall J, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346: 877-883.
4. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352: 225-237.
5. Solomon SD, Zelenkofske S, McMurray JJV, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005;352: 2581-2588.
6. Yap YG, Duong T, Bland M, et al. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicenter trials. Eur Heart J 2005;26: 1385-1393.
7. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351: 2481-2488.
8. Steinbeck G, Andresen D, Seidl K, et al. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009;361: 1427-1436.
9. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117:e350-e408.
10. Wilber DJ, Zareba W, Hall WJ, et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 2004;109: 1082-1084.
11. Al-Khatib SM, Hafley G, Lee KL, Buxton AE. Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial. Europace 2010;12: 1112-1118.
12. Piccini JP, Al-Khatib SM, Hellkamp AS, et al. Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Heart Rhythm 2011;8: 393-400.
13. Myerburg RJ. Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med 2008;359: 2245-2253.
14. Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation 2012;125: 1043-1052.
15. The Antiarrhythmics Versus Implantable Defibrillators Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337: 1576-1583.
16. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102: 748-754.
17. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350: 2151-2158.
18. Bigger JT, Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 1997;332: 1569-1575.
19. Moss AJ, Hall J, Cannom DS, et al. Improved survival with an implanted cardioverter-defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335: 1933-1940.
20. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341: 1882-1890.
21. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352: 225-237.
22. Lee KL, Hafley G, Fisher JD, et al. Effect of implantable defibrillators on arrhythmic events and mortality in the Multicenter UnSustained Tachycardia Trial. Circulation 2002;106: 233-238.
23. Ibrahim JG, Chen MH, Sinha D. Bayesian Survival Analysis. Springer-Verlag; 2001.
24. Lunn DJ, Thomas A, Best N, Spiegelhalter D. Winbugs-a Bayesian modelling framework. Concepts, structure, and extensibility. Stat Comput 2000;10: 325-337.
25. Buxton AE. Sudden death after myocardial infarction-who needs prophylaxis, and when? N Engl J Med 2005;352: 2638-2640.
26. Eckardt L, Haverkamp W, Johna R, et al. Arrhythmias in heart failure: current concepts of mechanisms and therapy. J Cardiovasc Electrophysiol 2000;11: 106-117.
27. Bunch TJ, Hohnloser SH, Gersh BJ. Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implant-able cardioverter-defibrillators. Circulation 2007;115: 2451-2457.
28. Piccini JP, Zhang M, Pieper K, et al. Predictors of sudden cardiac death change with time after myocardial infarction: results from the valiant trial. Eur Heart J 2010;31: 211-221.
29. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1990;327: 669-677.
30. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990;81: 1161-1172.
31. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008;52: 1111-1121.
32. Christensen R, Johnson W, Branscum A, Hanson TE. Bayesian ideas and data analysis: an introduction for scientists and statisticians. Boca Raton, FL: Chapman & Hall/CRC Press; 2011. 161-178.
33. Moss AJ, Greenberg H, Case RB, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110: 3760-3765.
34. Goldenberg I, Moss AJ, Hall WJ, et al. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2006;113: 2810-2817.